Patient-Derived Cancer Stem Cells Offer Diagnostic and Therapeutic Potential in Brain Cancer
March 1st 2017A brain tumor research group at the UW Carbone Cancer Center focuses on biological studies of patient-derived glioblastoma multiforme (GBM) cancer stem cells, combined with analysis of patient-matched serum-cultured GBM and an annotated GBM tissue microarray, to identify clinically relevant biomarkers.
UW Researchers Hope Understanding Collagen's Role in Breast Cancer Could Lead to a New Treatment
Researchers at the University of Wisconsin School of Medicine and Public Health have found that removing a specific type of collagen can dramatically reduce the growth of one form of breast cancer.
Minority Women Receive Poorer Care for Cervical Cancer
In a large-scale study published today in the journal Obstetrics and Gynecology, researchers found that nearly half of women from racial minorities receive cervical-cancer care that doesn’t meet national standards.
Wisconsin Cancer Patients Test Encouraging Lymphoma Treatment
Half of the patients in a Wisconsin Oncology Network (WON) clinical trial for a rare blood cancer are still in remission eight years after beginning treatment, according to new results of a follow-up to the study.
Carbone Cancer Center Clinical Trials Test Dietary Therapy for Triple-Negative Breast Cancer
A new clinical trial for women with clinically aggressive triple-negative breast cancer (TNBC) will test a novel theory: Will a diet low in an essential nutrient make TNBC cells more vulnerable to cell killing by a new cancer drug?
Dr. Rosenberg on Complexity of Online Patient Information From NCI Cancer Center Websites
July 6th 2015Stephen Rosenberg, MD, University of Wisconsin School of Medicine and Public Health, discusses a study examining if online patient information provided by National Cancer Institute (NCI)-designated cancer center websites is too complex for general readership.
Dr. O'Regan Discusses Breast Cancer Index in HER2-Positive/HR-Positive Patients
June 17th 2015Ruth O'Regan, MD, medical oncology, Breast Cancer Clinic, University of Wisconsin Carbone Cancer Center, faculty, University of Wisconsin School of Medicine and Public Health, evaluates the Breast Cancer Index in patients with HER2-positive, HR-positive breast cancer for risk of late recurrence and endocrine benefit.
University of Wisconsin Carbone Cancer Center: A Tradition of Comprehensive, Multidisciplinary Care
Currently, more than 250 physicians and scientists work in concert to provide state-of- the art diagnosis, treatment, and aftercare for the more than 20,000 patients seen each year at the UW hospitals, clinics, and affiliate clinical facilities